Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 4 1Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Completed 20Recruiting 6Active not recruiting 6Unknown 5Terminated 2Not yet recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 2Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 2Resectable Pancreatic Ductal Adenocarcinoma 1Melanoma 1Hand-Foot Skin Reaction (HFSR) 1

Interventions

Cisplatin 267Oxaliplatin 194Carboplatin 189Capecitabine 183Docetaxel 176apatinib 164Paclitaxel 158Bevacizumab 155Gemcitabine 154Radiotherapy 146camrelizumab 145Fluorouracil 144Cyclophosphamide 123Irinotecan 119Drug Therapy 118sintilimab 107Etoposide 99anlotinib 90S 1 (combination) 88Leucovorin 85pembrolizumab 82Pemetrexed 78Doxorubicin 77toripalimab 76tislelizumab 75Dexamethasone 70Trastuzumab 65Neoadjuvant Therapy 64Rituximab 62Cetuximab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Tablets × Clear all
NCT05370807 2023-10-24

RegoMel

Universitair Ziekenhuis Brussel

Phase 2 Unknown
48 enrolled
Dermatologic

Melanoma

NCT04389073 2022-02-25

Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Unknown
138 enrolled
Breast

Breast Neoplasms

NCT04242927 2020-04-01

A Study to Investigate Nicotinic Acid on VEGFR Inhibitor-Associated Hand-Foot Skin Reactions

First People's Hospital of Hangzhou

Phase 2 Unknown
36 enrolled

Hand-Foot Skin Reaction (HFSR)

NCT03024580 2019-08-15

MEGA

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown
20 enrolled
Breast

Breast Neoplasms

NCT02978547 2018-01-18

Metformin 001

British Columbia Cancer Agency

Phase 2 Unknown
20 enrolled
Gastrointestinal

Resectable Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡